Crispr Infuses First Human in Landmark Gene-Editing Study

Crispr Therapeutics and partner Vertex Pharmaceuticals said on Monday morning that the first patient in a trial using CTX001 received the one-time medicine.

from NDTV Gadgets - Latest https://ift.tt/2XjoJ5n

Comments

Popular posts from this blog

From Animal, Sam Bahadur to Griselda: Here Are the Top OTT Releases of This Week to Binge-Watch This Weekend

Younger Generations of Traders Favour AI Advancements in Crypto, Web3 Sector: KuCoin Report